Recent Updates
Recently added Catalysts
BLTE Positive Sentiment Score: 75/100

Belite Bio to Present at the JonesHealthcare Seaside Summit

Monday, July 8, 2024 1 min read
Key Takeaway: Belite Bio, Inc. is set to participate in the JonesHealthcare Seaside Summit on July 15, 2024. Dr. Nathan Mata, the Chief Scientific Officer, will deliver a corporate update regarding the company's efforts in developing novel therapeutics for degenerative retinal diseases. The presentation will be accessible via webcast, with a replay available for 90 days. This engagement underscores Belite Bio's commitment to tackling significant medical needs in ophthalmology.

Market Sentiment Analysis

POSITIVE FACTORS

  • Belite Bio is presenting at a significant healthcare summit.
  • Dr. Nathan Mata will provide a corporate update, highlighting potential advancements.
  • The company's focus on degenerative retinal diseases addresses significant unmet medical needs.

Full Press Release Details

SAN DIEGO, July 08, 2024 (GLOBE NEWSWIRE) -- Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that Dr. Nathan Mata, Chief Scientific Officer of Belite Bio, will participate in the JonesHealthcare Seaside Summit in Encinitas, CA, and present a corporate update on Monday, July 15, 2024, at 1:00 pm PT.
A webcast of the presentation can be accessed under the "Events" tab on the investor relations section of the Belite Bio website at: https://investors.belitebio.com/presentations-events/events. The replay will be archived for 90 days following the presentation date.
Media and Investor Relations Contact:
belite@argotpartners.com

Frequently Asked Questions

Who is presenting at the JonesHealthcare Seaside Summit?

Dr. Nathan Mata, Chief Scientific Officer of Belite Bio, will present.

When is the JonesHealthcare Seaside Summit presentation scheduled?

The presentation is on July 15, 2024, at 1:00 pm PT.

Where can I access the webcast of the presentation?

The webcast is available on the Belite Bio website under 'Events'.

How long will the presentation replay be available?

The replay will be archived for 90 days after the presentation.

What is Belite Bio focused on developing?

Belite Bio focuses on novel therapeutics for degenerative retinal diseases.

Tags: BLTE Viatris Investor Conferences Healthcare Belite Bio JonesHealthcare retinal diseases medical summit
Last updated: Jul 8, 2024